OpportunityTitle: Enhancing Cellular Immunity in the Female Reproductive Tract (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:   Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.    Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the discovery of mechanisms that mediate the induction and maintenance of effective antigen-specific CD8+ memory T cells in the female reproductive tract (FRT). The ultimate goal is to develop the knowledge base needed to facilitate the development of future vaccines that generate effective and persistent T lymphocyte responses against infection by HIV and other mucosal pathogens in the FRT. This program is not intended to support evaluation of mucosal vaccines or therapies, or research primarily focused on pathogens.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;